Notch3 signaling promotes the development of pulmonary arterial hypertension
- PMID: 19855400
- PMCID: PMC2780347
- DOI: 10.1038/nm.2021
Notch3 signaling promotes the development of pulmonary arterial hypertension
Abstract
Notch receptor signaling is implicated in controlling smooth muscle cell proliferation and in maintaining smooth muscle cells in an undifferentiated state. Pulmonary arterial hypertension is characterized by excessive vascular resistance, smooth muscle cell proliferation in small pulmonary arteries, leading to elevation of pulmonary vascular resistance, right ventricular failure and death. Here we show that human pulmonary hypertension is characterized by overexpression of NOTCH3 in small pulmonary artery smooth muscle cells and that the severity of disease in humans and rodents correlates with the amount of NOTCH3 protein in the lung. We further show that mice with homozygous deletion of Notch3 do not develop pulmonary hypertension in response to hypoxic stimulation and that pulmonary hypertension can be successfully treated in mice by administration of N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester (DAPT), a gamma-secretase inhibitor that blocks activation of Notch3 in smooth muscle cells. We show a mechanistic link from NOTCH3 receptor signaling through the Hairy and enhancer of Split-5 (HES-5) protein to smooth muscle cell proliferation and a shift to an undifferentiated smooth muscle cell phenotype. These results suggest that the NOTCH3-HES-5 signaling pathway is crucial for the development of pulmonary arterial hypertension and provide a target pathway for therapeutic intervention.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780347/bin/nihms144487f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780347/bin/nihms144487f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780347/bin/nihms144487f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780347/bin/nihms144487f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780347/bin/nihms144487f5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2780347/bin/nihms144487f6.gif)
Similar articles
-
Notch3 signaling activation in smooth muscle cells promotes extrauterine growth restriction-induced pulmonary hypertension.Nutr Metab Cardiovasc Dis. 2019 Jun;29(6):639-651. doi: 10.1016/j.numecd.2019.03.004. Epub 2019 Mar 13. Nutr Metab Cardiovasc Dis. 2019. PMID: 30954415
-
mTORC1 is involved in hypoxia-induced pulmonary hypertension through the activation of Notch3.J Cell Physiol. 2014 Dec;229(12):2117-25. doi: 10.1002/jcp.24670. J Cell Physiol. 2014. PMID: 24825564
-
Notch signaling change in pulmonary vascular remodeling in rats with pulmonary hypertension and its implication for therapeutic intervention.PLoS One. 2012;7(12):e51514. doi: 10.1371/journal.pone.0051514. Epub 2012 Dec 12. PLoS One. 2012. PMID: 23251561 Free PMC article.
-
NOTCH3 and Pulmonary Arterial Hypertension.Int J Mol Sci. 2024 Jun 6;25(11):6248. doi: 10.3390/ijms25116248. Int J Mol Sci. 2024. PMID: 38892440 Free PMC article. Review.
-
Notch signaling in pulmonary hypertension.Adv Exp Med Biol. 2010;661:279-98. doi: 10.1007/978-1-60761-500-2_18. Adv Exp Med Biol. 2010. PMID: 20204737 Review.
Cited by
-
Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again.Int J Mol Sci. 2024 Apr 26;25(9):4728. doi: 10.3390/ijms25094728. Int J Mol Sci. 2024. PMID: 38731946 Free PMC article. Review.
-
Inhibition of Notch3/Hey1 ameliorates peribiliary hypoxia by preventing hypertrophic hepatic arteriopathy in biliary atresia progression.Histochem Cell Biol. 2024 Jun;161(6):461-476. doi: 10.1007/s00418-024-02278-w. Epub 2024 Apr 10. Histochem Cell Biol. 2024. PMID: 38597939
-
Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.Drug Des Devel Ther. 2024 Mar 11;18:767-780. doi: 10.2147/DDDT.S444605. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38495631 Free PMC article.
-
Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants.Int J Mol Sci. 2024 Feb 27;25(5):2734. doi: 10.3390/ijms25052734. Int J Mol Sci. 2024. PMID: 38473983 Free PMC article.
-
Genetic determinants of blood pressure and heart rate identified through ENU-induced mutagenesis with automated meiotic mapping.Sci Adv. 2024 Mar;10(9):eadj9797. doi: 10.1126/sciadv.adj9797. Epub 2024 Mar 1. Sci Adv. 2024. PMID: 38427739 Free PMC article.
References
-
- Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767–801. - PubMed
-
- Yuan JX-J, Rubin LJ. Pathogenesis of pulmonary arterial hypertension: the need for multiple hits. Circulation. 2005;111:534–538. - PubMed
-
- Hyduk A, et al. Pulmonary hypertension surveillance – United States, 1980–2002. 2005;54(SS05):1–28. http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5405a1.htm. - PubMed
-
- Simonneau G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2004;43:5S–12S. - PubMed
-
- Alva JA, Iruela-Arispe ML. Notch signaling in vascular morphogenesis. Curr Opin Hematol. 2004;11:278–283. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous